Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Swift

Showing results (21-30 of 90) with videos related to

Pageof 9
Sort By:
CNS Drugs|March 7, 2007
Pharmacotherapy of dual substance abuse and dependenceGeorge A Kenna, Darci M Nielsen, Patricia Mello, et al.
Psychopharmacology|April 9, 2011
Effects of contingency management and bupropion on cigarette smoking in smokers with schizophreniaJennifer W Tidey, Damaris J Rohsenow, Gary B Kaplan, et al.
Alcoholism, Clinical and Experimental Research|January 31, 2006
Advances in the pharmacotherapy of alcoholism: challenging misconceptionsHenry R Kranzler, George Koob, David R Gastfriend, et al.
CNS Drugs|July 10, 2025
Psychedelics for Alcohol Use Disorder: A Narrative Review with Candidate Mechanisms of ActionEric A Miller, Christy Capone, Erica Eaton, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|June 28, 2008
Effects of smoking abstinence, smoking cues and nicotine replacement in smokers with schizophrenia and controlsJennifer W Tidey, Damaris J Rohsenow, Gary B Kaplan, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 21, 2012
Separate and combined effects of very low nicotine cigarettes and nicotine replacement in smokers with schizophrenia and controlsJennifer W Tidey, Damaris J Rohsenow, Gary B Kaplan, et al.
Alcoholism, Clinical and Experimental Research|November 10, 2010
Role of feeding-related pathways in alcohol dependence: A focus on sweet preference, NPY, and ghrelinLorenzo Leggio, Giovanni Addolorato, Andrea Cippitelli, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 31, 2003
Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interactionKent E Hutchison, Angela Wooden, Robert M Swift, et al.
Psychopharmacology|March 26, 2004
Olanzapine attenuates cue-elicited craving for tobaccoKent E Hutchison, Marie-Christine Rutter, Raymond Niaura, et al.
Current Pharmaceutical Design|May 21, 2010
Turning the clock ahead: potential preclinical and clinical neuropharmacological targets for alcohol dependenceLorenzo Leggio, Silvia Cardone, Anna Ferrulli, et al.
Pageof 9

Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
CNS Drugs|March 7, 2007
Pharmacotherapy of dual substance abuse and dependenceGeorge A Kenna, Darci M Nielsen, Patricia Mello, et al.
Psychopharmacology|April 9, 2011
Effects of contingency management and bupropion on cigarette smoking in smokers with schizophreniaJennifer W Tidey, Damaris J Rohsenow, Gary B Kaplan, et al.
Alcoholism, Clinical and Experimental Research|January 31, 2006
Advances in the pharmacotherapy of alcoholism: challenging misconceptionsHenry R Kranzler, George Koob, David R Gastfriend, et al.
CNS Drugs|July 10, 2025
Psychedelics for Alcohol Use Disorder: A Narrative Review with Candidate Mechanisms of ActionEric A Miller, Christy Capone, Erica Eaton, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|June 28, 2008
Effects of smoking abstinence, smoking cues and nicotine replacement in smokers with schizophrenia and controlsJennifer W Tidey, Damaris J Rohsenow, Gary B Kaplan, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 21, 2012
Separate and combined effects of very low nicotine cigarettes and nicotine replacement in smokers with schizophrenia and controlsJennifer W Tidey, Damaris J Rohsenow, Gary B Kaplan, et al.
Alcoholism, Clinical and Experimental Research|November 10, 2010
Role of feeding-related pathways in alcohol dependence: A focus on sweet preference, NPY, and ghrelinLorenzo Leggio, Giovanni Addolorato, Andrea Cippitelli, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 31, 2003
Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interactionKent E Hutchison, Angela Wooden, Robert M Swift, et al.
Psychopharmacology|March 26, 2004
Olanzapine attenuates cue-elicited craving for tobaccoKent E Hutchison, Marie-Christine Rutter, Raymond Niaura, et al.
Current Pharmaceutical Design|May 21, 2010
Turning the clock ahead: potential preclinical and clinical neuropharmacological targets for alcohol dependenceLorenzo Leggio, Silvia Cardone, Anna Ferrulli, et al.
Pageof 9